First Tracks Biotherapeutics, Inc. (TRAX)
Market Closed
15 Jun, 20:00
NASDAQ (NGS) NASDAQ (NGS) Primary 
XDUS $
17. 88
+0.24
+1.3605%
After Hours
$
+1.17 +6.5436% 19. 05
579.21M Market Cap
- P/E Ratio
- Div Yield
93,013 Volume
- Eps
$ 17.64
Previous Close Want to track TRAX and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
First Tracks Biotherapeutics, Inc. (TRAX) Statistics
Valuation metrics
Market Cap 579.21M
Enterprise value 367.03M
Trailing P/E (ttm) -6.28
Forward P/E -
PEG ratio -0.06
Price/Sales (ttm) -
Price/Book (mrq) 2.38
Enterprise Value/Revenue -
Enterprise Value/EBITDA -3.55
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 544.54K
Average volume (90 days) 540.46K
Price summary
52-Week low 14.72
52-Week high 26.8
Beta -
50-Day moving average 18.05
200-Day moving average 17.45
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -
Operating margin -
Operational effectiveness
Return on assets -0.34%
Return on equity -0.3%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) -
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -2.81
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 8.24
Total debt (mrq) -
Total Debt/Equity (mrq) -
Current ratio (mrq) 8.74%
Book value per share (mrq) 7.41
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
